-transparent.png){kind=logo}
The B antigen activity was severely diminished in a patient's RBCs at the preleukemic stage prior to chemo- or radiotherapy. The amount of H sites of the patient's RBC membranes was found to be comparable to that of O RBC membranes. The activity of alpha (1----2) fucosyltransferase (H enzyme) was not severely decreased in the patient's plasma and bone marrow. However, the activity of alpha (1----3) galactosyltransferase (B enzyme), which converts H substance to B substance, was drastically reduced in the patient's bone marrow. Thus, the diminished B antigen in the patient's RBCs was caused mainly by the blockage of conversion of the H substance to B substance. It is suggested that the viral oncogene linked to the ABO locus at q34 of chromosome No. 9 would occasionally suppress the expression of blood group A and B enzymes and A and B antigens.
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
February 1982,
Blood,
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
February 1978,
Revue francaise de transfusion et immuno-hematologie,
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
January 1991,
Immunohematology,
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
December 1992,
Transplantation proceedings,
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
November 1993,
Zentralblatt fur Pathologie,
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
December 1980,
FEBS letters,
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
February 1979,
Haematologica,
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
October 2006,
Journal of the American Chemical Society,
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
May 1968,
The Biochemical journal,
A Yoshida, and
T Kumazaki, and
V Davé, and
J Blank, and
W H Dzik
April 1984,
British journal of urology,
